Takeda Announces Appointment of New Senior Leadership

September 30, 2014

Osaka, Japan, September 30, 2014 --- Takeda Pharmaceutical Company Limited today announced the new appointment of senior leadership. The details are as follows:

Ÿ ・  New appointment of the Corporate Officers effective October 1, 2014:

Assignment Name
Global General Counsel Yoshihiro Nakagawa
President, Global Oncology Business Unit Christophe Bianchi
President, Global Vaccine Business Unit Rajeev Venkayya
President, Emerging Markets Business Unit Giles Platford
Global Manufacturing and Supply Officer Thomas Wozniewski
Global Quality Officer Gerard Greco
Global Compliance Officer Mwana Lugogo

Ÿ ・  ŸNew senior leadership effective October 1, 2014:

New assignment Previous assignment Name
Corporate Officer,
Corporate Communications & Public Affairs Officer,
Senior Vice President,
Corporate Communications Department
(Corporate Officer,
Senior Vice President,
Head of North Asia)

Haruhiko Hirate

###